INOVIO to Report First Quarter Financial Results on May 13, 2026

Rhea-AI Summary

INOVIO (NASDAQ:INO) will release its first quarter 2026 financial results after market close on May 13, 2026. A live conference call and webcast will follow at 4:30 p.m. ET for a financial review and general business update, with a listen-only format and live Q&A.

The webcast will be archived and available for replay for 90 days at the company's investor events page.

News Market Reaction – INO

+3.64%

+3.64% Session close to close

In the May 4 session, INO gained 3.64%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets expectations for Q1 2026 results on May 13, 2026 with a 4:30 p.m. ET webcast ...

Analysis

This announcement sets expectations for Q1 2026 results on May 13, 2026 with a 4:30 p.m. ET webcast and a 90-day replay. Context includes recent 2025 results featuring a narrowed $84.9M net loss, cash of $58.5M, and a PDUFA date of October 30, 2026 for INO-3107, followed by a $17.5M public offering. Investors may focus on Q1 cash burn, pipeline progress, and any updates to regulatory timelines.

Key Figures

Q1 2026 results date: May 13, 2026 Conference call time: 4:30 p.m. ET Webcast replay period: 90 days

3 metrics

Q1 2026 results date May 13, 2026 Scheduled release after market close

Conference call time 4:30 p.m. ET Start of earnings call and webcast

Webcast replay period 90 days Archive duration for Q1 2026 webcast

Previous Earnings date Reports

1 past event · Latest: Mar 05 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Mar 05	Earnings date notice	Neutral	+3.6%	Announced timing of Q4 and full-year 2025 results and related webcast.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Limited history for ‘earnings date’ headlines; the prior notice of results was followed by a modest positive move.

Recent Company History

Over recent months INOVIO has combined financing activity, regulatory milestones, and scientific visibility. In March 2026, it reported 2025 results and highlighted BLA acceptance for INO-3107 with a PDUFA date of October 30, 2026, alongside reduced operating expenses and a narrowed $84.9M net loss. An April $17.5M public offering pressured the stock. Today’s announcement simply schedules Q1 2026 results for May 13, 2026, similar in structure to the prior earnings-date notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PLYMOUTH MEETING, Pa., May 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that its first quarter 2026 financial results will be released after the market close on May 13th, 2026. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss the financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing innovative DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com

Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, investor.relations@inovio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-first-quarter-financial-results-on-may-13-2026-302760436.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO (INO) report first quarter 2026 financial results?

INOVIO will release first quarter 2026 results after market close on May 13, 2026. According to the company, the announcement will be followed by a live webcast and conference call at 4:30 p.m. ET to review results and provide a business update.

How can investors join the INOVIO (INO) May 13, 2026 earnings webcast?

Investors can access the live webcast via the company's investor events page. According to the company, the webcast is listen-only but includes a live Q&A with analysts and will be streamed at the posted URL.

Will the INOVIO (INO) earnings webcast be available after the live event?

Yes, the webcast will be archived and available for replay for 90 days after the event. According to the company, archived access will remain on the investor events page for investors who cannot attend live.

What time is INOVIO's (INO) conference call on May 13, 2026?

The conference call and webcast are scheduled for 4:30 p.m. ET on May 13, 2026. According to the company, the session will cover first quarter 2026 financial results and provide a general business update with analyst Q&A.

Where is the official webcast link for INOVIO (INO) Q1 2026 results?

The official webcast link is available on INOVIO's investor events page at the company's website. According to the company, the webpage hosts the live stream and the archived replay for 90 days following the event.